SNDX
Syndax Pharmaceuticals Inc
17.60$
-3.4%
vs. previous close
Closing price · As of: Oct 2, 2026
Statements
Income Statement
All figures per share in USD.
Tick rows to compare them in a chart (up to 4)
| Line item | Q3 23 | Q4 23 | Q1 24 | Q2 24 | Q3 24 | Q4 24 | Q1 25 | Q2 25 | Q3 25 | Q4 25 | Q1 26 | Q2 26 | LTM* |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 0.00 | 0.01 | 0.00 | 0.04 | 0.15 | 0.09 | 0.23 | 0.44 | 0.53 | 0.79 | 0.75 | 0.82 | 2.83 | |
| 0.00 | 0.00 | 0.00 | 0.52 | 0.00 | 0.01 | 0.01 | 0.01 | 0.02 | -0.02 | 0.03 | 0.04 | 0.07 | |
| 0.00 | 0.00 | 0.00 | 0.04 | 0.15 | 0.09 | 0.22 | 0.42 | 0.51 | 0.81 | 0.72 | 0.78 | 2.76 | |
| 0.56 | 0.76 | 0.66 | 0.57 | 0.83 | 0.76 | 0.72 | 0.72 | 0.65 | 0.91 | 0.68 | 0.76 | 2.94 | |
| 0.25 | 0.61 | 0.27 | 0.34 | 0.36 | 0.44 | 0.48 | 0.51 | 0.52 | 0.58 | 0.43 | 0.47 | 1.95 | |
| 0.81 | 1.07 | 0.93 | 0.91 | 1.19 | 1.21 | 1.20 | 1.23 | 1.17 | 1.53 | 1.11 | 1.23 | 4.94 | |
| -0.81 | -1.07 | -0.93 | -0.87 | -1.05 | -1.12 | -0.98 | -0.80 | -0.66 | -0.72 | -0.39 | -0.45 | -2.18 | |
| 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.06 | 0.09 | 0.09 | 0.10 | 0.61 | 0.14 | 0.14 | 0.96 | |
| -0.73 | -1.00 | -0.85 | -0.80 | -0.98 | -1.10 | -0.99 | -0.83 | -0.70 | -0.79 | -0.49 | -0.55 | -2.48 | |
| 0.00 | 0.07 | 0.00 | – | 0.00 | – | – | – | – | – | – | – | – | |
| -0.73 | -1.00 | -0.85 | -0.80 | -0.98 | -1.10 | -0.99 | -0.83 | -0.70 | -0.79 | -0.49 | -0.55 | -2.48 | |
| -0.73 | -1.00 | -0.85 | -0.80 | -0.98 | -1.04 | -0.98 | -0.74 | -0.61 | -0.18 | -0.36 | -0.41 | -1.52 |
LTM = last twelve months (sum of the four most recent quarters).
Data as of: October 2, 2026 · Source: fundamental data & SEC filings (annual and quarterly reports, 10-K/10-Q)
Note: pure fact-based analysis, not investment advice and not a solicitation to buy or sell. All figures without guarantee.